09:30 WELCOME ADDRESS
CHRISTOPH PLASS, Editor-in-Chief International Journal of Cancer, DKFZ, Heidelberg, Germany
09:45 SESSION I Chair: Christoph Plass
ANGELIKA FELDMANN, DKFZ, Heidelberg, Germany
Dynamic regulation of 3D genome structure and its relationship with gene activation
ZUZANA TOTHOVA, Dana-Farber Cancer Institute, Boston, USA
Cohesin mutations and chromatin changes in cancer
JOP KIND, Hubrecht Institute, Utrecht, Netherlands
Single-cell epigenomics in cancer research
11:15 Coffee break
SESSION II Chair: Hinrich Gronemeyer
KARSTEN RIPPE, DKFZ, Heidelberg, Germany
TBA
CHRISTOPH PLASS, DKFZ, Heidelberg, Germany
Enhancer Hijacking in AML
12:45 Lunch break
14:00 SESSION III Chair: Christoph Plass
AURORE TOUZART, APHP-Centre-Université Paris Cité, France
Neo-enhancers in T-cell Acute Lymphoblastic Leukaemia (T-ALL) and beyond
MATHIEU LUPIEN, University of Toronto, Canada
Epigenomic heterogeneity in prostate cancer
RUUD DELWEL, Erasmus MS Cancer Institute, Rotterdam, Netherlands
How good enhancers can make good genes Evil.
15:30 Coffee break
16:00 SESSION IV Chair: Ruud Delwel
FLORIAN PERNER, Medizinische Hochschule Hannover, Germany
Leukemia cell persistence under Menin inhibitor treatment
MICHAEL LÜBBERT, University Medical Center Freiburg, Germany
DNMT1 inhibitor-based reduced-toxicity induction: is successful bridge-to-transplant a road to cure only for older AML patients?
17:00 CONLCUSION REMARKS
